Europe approves Western world’s first stem-cell therapy for rare eye condition – Reuters
www.worldbulletin.net |
Europe approves Western world's first stem–cell therapy for rare eye condition
Reuters Holoclar, from privately held Italian company Chiesi, was given a marketing green light on Friday by the European Commission for treating so-called limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result … Europe okay for first stem–cell therapy – Chiesi's Holoclar |
